.png)
Our Mission
At the heart of our services is our commitment to leveraging the diverse expertise of physicians across various sub-specialties, ensuring the highest level of precision and insight.
We are dedicated to delivering exemplary customer service, cutting-edge evaluations, and tailored solutions that meet the evolving needs of our clients. Our efficiency and timeliness in delivering results set us apart, making GI Reviewers your trusted partners in advancing medical research and development.
Founded in 2012, GIR was created to centralize the blinded imaging review process among top leaders in gastroenterology. Expanding in 2017, GIR now offers a comprehensive suite of trial solutions across multiple fields, including Radiology/Oncology, Musculoskeletal Imaging, ENT, Cardiology, Pathology, and more.
Our hands-on, customer-driven approach ensures that your priorities are our priorities. We hold our team to the highest industry standards for quality, accuracy, and timeliness, ensuring your clinical trial runs smoothly and efficiently.
At the heart of GIR’s mission is our unwavering commitment to meeting your needs for every trial.
Contact us today to learn more about how GIR can make an impact on your next project.
Daniel Mishkin MD, CM, FRCP(C), FASGE, FACG, AGAF
Founder and CEO, GI Reviewers
Dr. Daniel Mishkin, MD, is a highly skilled and board-certified gastroenterologist known for his expertise in diagnosing and managing a wide range of gastrointestinal conditions. With extensive training and a patient-centered approach, Dr. Mishkin provides advanced care for disorders related to the digestive system, including the stomach, intestines, liver, and pancreas.
Dr. Mishkin completed his medical education at a McGill University, followed by comprehensive residency and fellowship programs that honed his expertise in gastroenterology. With years of clinical experience, he is recognized for his commitment to providing high-quality, personalized patient care.
His practice emphasizes state-of-the-art diagnostic procedures, effective treatment plans, and a compassionate approach to patient well-being. Affiliated with multiple renowned hospitals, including Beth Israel Deaconess Medical Center and Harvard Medical School, Dr. Mishkin is actively involved in both clinical practice and research.
His dedication to advancing gastroenterological care is evident through his contributions to medical research and his participation in professional medical communities. Dr. Mishkin is also known for his involvement in academic medicine, sharing his knowledge with peers and students alike.
Patients appreciate Dr. Mishkin's thoroughness, clear communication, and ability to offer tailored treatment options that align with the latest medical guidelines. His clinical interests include inflammatory bowel disease, colorectal cancer screening, liver disease, and advanced endoscopic procedures.
As a top-rated physician on various medical platforms, he continues to be a trusted and respected name in the field of gastroenterology. He is recognized by Castle Connolly as a top doctor in gastroenterology, a testament to his dedication and excellence in patient care.